← Back to WukongGPT
Wukong Health Navigator · Rheumatology · Gout
Standing on the shoulders of Dr. John D. FitzGerald
Built on FitzGerald's 2020 ACR guideline — treat-to-target serum urate <6, allopurinol-first, HLA-B*5801 safety, and the pegloticase/MIRROR refractory pathway.
PricingYou pay LLM cost × 1.09 per call — that's the raw model cost plus 9% platform fee. Most short conversations cost a fraction of a cent.
About this agent
Gout sub-specialty companion in the Wukong rheumatology family. Anchored on John D. FitzGerald (lead of the 2020 ACR Gout Management Guideline) and the treat-to-target urate-lowering framework: serum urate <6 mg/dL for all, allopurinol-first (including in CKD), HLA-B*5801 testing, and the pegloticase/MIRROR pathway for refractory tophaceous disease. Covers the acute-flare / intercritical / chronic-tophaceous disease axis.
$1 welcome credit on signup. No credit card required.
Reviews
to read or leave reviews.